Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Autoimmunity Reviews|December 25, 2010
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseasesS van Assen, O Elkayam, N Agmon-Levin, et al.
Annals of the Rheumatic Diseases|December 7, 2010
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesS van Assen, N Agmon-Levin, O Elkayam, et al.
Annals of the Rheumatic Diseases|April 17, 2008
EULAR recommendations for the management of primary small and medium vessel vasculitisC Mukhtyar, L Guillevin, M C Cid, et al.
Lupus|April 20, 2012
Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritisH A Martens, H L A Nienhuis, S Gross, et al.
Annals of the Rheumatic Diseases|April 17, 2008
EULAR recommendations for the management of large vessel vasculitisC Mukhtyar, L Guillevin, M C Cid, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoidsE M Miloslavsky, U Specks, P A Merkel, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.
Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitisE M Miloslavsky, U Specks, P A Merkel, et al.
Pageof 8